Global Digital Therapeutics Market Trend and Development Strategy Analysis 2023-2029

Report ID: ARS12496 | Category: Agriculture | Pages: 117 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$2950.00 Multi User-$5500.00

Report Description
View Table of Contents

Report Summary

Market Analysis and Insights: Global Digital Therapeutics Market
The global Digital Therapeutics market size in 2022 is 3160.0 million US dollars, and it is expected to be 17692.2 million US dollars by 2029, with a compound annual growth rate of 27.90% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Digital Therapeutics market include Omada Health Inc. (US), WellDoc Inc. (US), 2Morrow Inc (US)., Livongo Health (US), and Propeller Health (US). The share of the top 3 players in the Digital Therapeutics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Digital Therapeutics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Diabetes accounted for XX% of Digital Therapeutics market in 2022. Obesity share of XX%.
Diabetes accounted for XX% of the Digital Therapeutics market in 2022. Obesity accounts for XX%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital Therapeutics market.

Global Digital Therapeutics Scope and Market Size
Digital Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digital Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource.

The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Digital Therapeutics industry is considered in the report, covering the dynamic analysis of the development of the Digital Therapeutics industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapters 2-4: Segmented the global Digital Therapeutics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Digital Therapeutics market country revenue data, and includes PEST Analysis.
Chapter 10: Analysis of the competitive environment of Digital Therapeutics market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Digital Therapeutics industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed Digital Therapeutics market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Omada Health Inc. (US)
WellDoc Inc. (US)
2Morrow Inc (US).
Livongo Health (US)
Propeller Health (US)
Pear Therapeutics (US)
Canary Health Inc. (US)
Noom Health Inc. (US)
Mango Health Inc. (US)
Akili Interactive Labs (South Africa)
Better Therapeutics (US)
Happify Health (US)
Kaia Health (US)
Medtronic Plc. (Ireland)
Teladoc Health Inc (US)

Types list
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others

Application list
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others

Table of Content

1 Digital Therapeutics Market Introduction and Overview
1.1 Digital Therapeutics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Digital Therapeutics Industry Dynamic Analysis
1.5.1 Digital Therapeutics Market Trends Analysis
1.5.2 Digital Therapeutics Market Drivers Analysis
1.5.3 Digital Therapeutics Market Challenges Analysis
1.5.4 Digital Therapeutics Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Digital Therapeutics Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Digital Therapeutics Revenue and Share by Type
3 Global Digital Therapeutics Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Digital Therapeutics Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Digital Therapeutics Market Size (2018-2023)
4.2 Digital Therapeutics Growth Insights by Regions
4.2.1 Digital Therapeutics Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Digital Therapeutics Revenue Market Size by Regions (2018-2023)
4.2.3 North America Digital Therapeutics Market Size (2018-2023)
4.2.4 Europe Digital Therapeutics Market Size (2018-2023)
4.2.5 Asia-Pacific Digital Therapeutics Market Size (2018-2023)
4.2.6 Latin America Digital Therapeutics Market Size (2018-2023)
4.2.7 Middle East & Africa Digital Therapeutics Market Size (2018-2023)
5 North America
5.1 North America Digital Therapeutics Revenue by Countries
5.1.1 North America Digital Therapeutics Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Digital Therapeutics Revenue by Countries
6.1.1 Asia Pacific Digital Therapeutics Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Digital Therapeutics Revenue by Countries
7.1.1 Europe Digital Therapeutics Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Digital Therapeutics Revenue by Countries
8.1.1 Latin America Digital Therapeutics Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Digital Therapeutics Revenue by Countries
9.1.1 Middle East & Africa Digital Therapeutics Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Digital Therapeutics Market Competition, by Players
10.1 Global Digital Therapeutics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Digital Therapeutics Players Market Share in 2022
10.2.2 Top 6 Digital Therapeutics Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Digital Therapeutics Players Head Office, Business Provided
10.4 Digital Therapeutics Mergers & Acquisitions
10.5 Digital Therapeutics New Entrants and Expansion Plans
11 Players Profiles
11.1  Omada Health Inc. (US)
11.1.1 Omada Health Inc. (US) Company Profile
11.1.2 Digital Therapeutics Product Overview
11.1.3 Omada Health Inc. (US) Digital Therapeutics Market Performance (2018-2023)
11.1.4 Omada Health Inc. (US) Business Overview
11.1.5 Recent Developments and Plans
11.2  WellDoc Inc. (US)
11.2.1 WellDoc Inc. (US) Company Profile
11.2.2 Digital Therapeutics Product Overview
11.2.3 WellDoc Inc. (US) Digital Therapeutics Market Performance (2018-2023)
11.2.4 WellDoc Inc. (US) Business Overview
11.2.5 Recent Developments and Plans
11.3  2Morrow Inc (US).
11.3.1 2Morrow Inc (US). Company Profile
11.3.2 Digital Therapeutics Product Overview
11.3.3 2Morrow Inc (US). Digital Therapeutics Market Performance (2018-2023)
11.3.4 2Morrow Inc (US). Business Overview
11.3.5 Recent Developments and Plans
11.4  Livongo Health (US)
11.4.1 Livongo Health (US) Company Profile
11.4.2 Digital Therapeutics Product Overview
11.4.3 Livongo Health (US) Digital Therapeutics Market Performance (2018-2023)
11.4.4 Livongo Health (US) Business Overview
11.4.5 Recent Developments and Plans
11.5  Propeller Health (US)
11.5.1 Propeller Health (US) Company Profile
11.5.2 Digital Therapeutics Product Overview
11.5.3 Propeller Health (US) Digital Therapeutics Market Performance (2018-2023)
11.5.4 Propeller Health (US) Business Overview
11.5.5 Recent Developments and Plans
11.6  Pear Therapeutics (US)
11.6.1 Pear Therapeutics (US) Company Profile
11.6.2 Digital Therapeutics Product Overview
11.6.3 Pear Therapeutics (US) Digital Therapeutics Market Performance (2018-2023)
11.6.4 Pear Therapeutics (US) Business Overview
11.6.5 Recent Developments and Plans
11.7  Canary Health Inc. (US)
11.7.1 Canary Health Inc. (US) Company Profile
11.7.2 Digital Therapeutics Product Overview
11.7.3 Canary Health Inc. (US) Digital Therapeutics Market Performance (2018-2023)
11.7.4 Canary Health Inc. (US) Business Overview
11.7.5 Recent Developments and Plans
11.8  Noom Health Inc. (US)
11.8.1 Noom Health Inc. (US) Company Profile
11.8.2 Digital Therapeutics Product Overview
11.8.3 Noom Health Inc. (US) Digital Therapeutics Market Performance (2018-2023)
11.8.4 Noom Health Inc. (US) Business Overview
11.8.5 Recent Developments and Plans
11.9  Mango Health Inc. (US)
11.9.1 Mango Health Inc. (US) Company Profile
11.9.2 Digital Therapeutics Product Overview
11.9.3 Mango Health Inc. (US) Digital Therapeutics Market Performance (2018-2023)
11.9.4 Mango Health Inc. (US) Business Overview
11.9.5 Recent Developments and Plans
11.10  Akili Interactive Labs (South Africa)
11.10.1 Akili Interactive Labs (South Africa) Company Profile
11.10.2 Digital Therapeutics Product Overview
11.10.3 Akili Interactive Labs (South Africa) Digital Therapeutics Market Performance (2018-2023)
11.10.4 Akili Interactive Labs (South Africa) Business Overview
11.10.5 Recent Developments and Plans
11.11  Better Therapeutics (US)
11.11.1 Better Therapeutics (US) Company Profile
11.11.2 Digital Therapeutics Product Overview
11.11.3 Better Therapeutics (US) Digital Therapeutics Market Performance (2018-2023)
11.11.4 Better Therapeutics (US) Business Overview
11.11.5 Recent Developments and Plans
11.12  Happify Health (US)
11.12.1 Happify Health (US) Company Profile
11.12.2 Digital Therapeutics Product Overview
11.12.3 Happify Health (US) Digital Therapeutics Market Performance (2018-2023)
11.12.4 Happify Health (US) Business Overview
11.12.5 Recent Developments and Plans
11.13  Kaia Health (US)
11.13.1 Kaia Health (US) Company Profile
11.13.2 Digital Therapeutics Product Overview
11.13.3 Kaia Health (US) Digital Therapeutics Market Performance (2018-2023)
11.13.4 Kaia Health (US) Business Overview
11.13.5 Recent Developments and Plans
11.14  Medtronic Plc. (Ireland)
11.14.1 Medtronic Plc. (Ireland) Company Profile
11.14.2 Digital Therapeutics Product Overview
11.14.3 Medtronic Plc. (Ireland) Digital Therapeutics Market Performance (2018-2023)
11.14.4 Medtronic Plc. (Ireland) Business Overview
11.14.5 Recent Developments and Plans
11.15  Teladoc Health Inc (US)
11.15.1 Teladoc Health Inc (US) Company Profile
11.15.2 Digital Therapeutics Product Overview
11.15.3 Teladoc Health Inc (US) Digital Therapeutics Market Performance (2018-2023)
11.15.4 Teladoc Health Inc (US) Business Overview
11.15.5 Recent Developments and Plans
12 Global Digital Therapeutics Forecast Market Insights by Type
12.1 Global Digital Therapeutics Revenue Market Forecast by Type (2023-2029)
13 Global Digital Therapeutics Forecast Market Insights by Application
13.1 Digital Therapeutics Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Digital Therapeutics Forecast Market Size (2023-2029)
14.2 Digital Therapeutics Growth Forecast Insights by Regions
14.2.1 Digital Therapeutics Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Digital Therapeutics Forecast Market Size (2023-2029)
14.2.3 Europe Digital Therapeutics Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Digital Therapeutics Forecast Market Size (2023-2029)
14.2.5 Latin America Digital Therapeutics Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Digital Therapeutics Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Digital Therapeutics Market Trend and Development Strategy Analysis 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?